Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.Fed Regist. 2002 Feb 08; 67(27):5942-3.FR
The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. This final rule is part of FDA's ongoing review of OTC drug products.